Life AI Net
Start
Archiv
Rechner
Verzeichnis
Newsletter
Hot
Anmelden
Deutsch
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Start
Archiv
Rechner
Verzeichnis
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Anmelden
Start
Archiv
Rechner
Verzeichnis
More
Live
FierceBiotech
Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
Agilent
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Waters
Waters introduces biphenyl LC columns with low UV bleed and wide pH stability for improved aromatic separations - Chromatography Today
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com India
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
FierceBiotech
Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
Agilent
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Waters
Waters introduces biphenyl LC columns with low UV bleed and wide pH stability for improved aromatic separations - Chromatography Today
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com India
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
Archiv
Suchen
Suchen
Aktuell
Älteste
Löschen
@BioWorld
Gesamt
1062
Quelle
BioWorld
Suche
--
BioWorld
26. Feb. 2026
Gan & Lee Pharmaceuticals patents SMARCA2/4-degrading PROTACs
BioWorld
26. Feb. 2026
Cathepsin L inhibitors disclosed in Biofront Therapeutics patent
BioWorld
26. Feb. 2026
MSD patent details new WRN inhibitors for cancer
BioWorld
26. Feb. 2026
Retex Pharmaceuticals divulges vasopressin V2 receptor antagonists
BioWorld
25. Feb. 2026
Appointments and advancements for Feb. 25, 2026
BioWorld
25. Feb. 2026
Financings for Feb. 25, 2026
BioWorld
25. Feb. 2026
In the clinic for Feb. 25, 2026
BioWorld
25. Feb. 2026
Other news to note for Feb. 25, 2026
BioWorld
25. Feb. 2026
Regulatory actions for Feb. 25, 2026
BioWorld
25. Feb. 2026
Covant Therapeutics patents FcRn antagonists
BioWorld
25. Feb. 2026
Blossomhill Therapeutics reports new EGFR inhibitors
BioWorld
25. Feb. 2026
PARG inhibitors disclosed in Avelos Therapeutics patent
BioWorld
25. Feb. 2026
Shanghai Meiyue Biotech patents divulge c-KIT inhibitors
BioWorld
25. Feb. 2026
Waverley Pharma synthesizes PARP-1 inhibitors
BioWorld
24. Feb. 2026
Appointments and advancements for Feb. 24, 2026
BioWorld
24. Feb. 2026
Financings for Feb. 24, 2026
BioWorld
24. Feb. 2026
In the clinic for Feb. 24, 2026
BioWorld
24. Feb. 2026
Regulatory actions for Feb. 24, 2026
Zurück
22 / 59
Weiter